Loading...
Market
What will be Huma Therapeutics' revenue growth in 2024?
3
Resolution / Starting Odds
Less than 50% • 25%
50% to 100% • 25%
100% to 200% • 25%
More than 200% • 25%
Annual financial reports from Huma Therapeutics
Story
Huma Therapeutics Raises $80M in Series D, Near-$1B Valuation
Jul 16, 2024, 11:02 AM
Huma Therapeutics, a London-based healthcare startup, has successfully raised $80 million in a Series D funding round, bringing its total funding to $300 million and valuing the company at nearly $1 billion. The funding round saw participation from notable investors including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer. Huma uses AI to help developers create health applications and aims to turn text into healthcare apps using generative AI. The startup is often referred to as the 'Shopify of digital health' and its underlying models can develop a healthcare application prototype in minutes with just a simple user prompt.
View original story
Similar markets
0-10% • 25%
10-20% • 25%
20-30% • 25%
More than 30% • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Below 50% • 25%
50% - 74% • 25%
75% - 99% • 25%
100% or more • 25%
Less than 50% • 25%
50% to 100% • 25%
100% to 150% • 25%
More than 150% • 25%
Less than 3% • 25%
3% to 4% • 25%
4% to 5% • 25%
More than 5% • 25%
Less than $3 billion • 25%
$3 billion to $3.5 billion • 25%
$3.5 billion to $4 billion • 25%
More than $4 billion • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than $100 million • 25%
$100 million to $200 million • 25%
$200 million to $300 million • 25%
More than $300 million • 25%
Less than $50 million • 25%
$50 million - $100 million • 25%
$100 million - $200 million • 25%
More than $200 million • 25%
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
More than 20% increase • 25%
10%-20% increase • 25%
0%-10% increase • 25%
Decrease • 25%